Concepedia
Statistics
Publications
20
Citations
819
H-Index
14
Active since
2018
Affiliations
Wuhan University(Current)
Hubei Provincial Center for Disease Control and Prevention
Zhongnan Hospital of Wuhan University
Ningbo University
Chengdu University of Traditional Chinese Medicine
Mengting Li is an author at Wuhan University specializing in medicine, oncology, and molecular oncology.
Publications per year
2018–2024
Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis
Qian Hu, Wanhui Wei, Daiqian Wu et al. · Frontiers in Cell and Developmental Biology · 2022 · 178 citations · Full text
Medicine, Oncology, Pharmacology +14
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
Yanan Peng, Chang Liu, Mengting Li et al. · Cancer Cell International · 2021 · 140 citations · Full text
Medicine, Immunology, Oncology +17
Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway
Shouquan Dong, Yuanyuan Lu, Ganjing Peng et al. · Digestive and Liver Disease · 2021 · 83 citations
Life Sciences, Cell Biology, Immunology +16
Erianin inhibits human lung cancer cell growth via <scp>PI3K</scp>/Akt/<scp>mTOR</scp> pathway in vitro and in vivo
Huiqiong Zhang, G X Li, Junren Chen et al. · Phytotherapy Research · 2021 · 65 citations
Medicine, Oncology, Pharmacology +12
Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal‑regulated kinase signaling pathway
Mengting Li, Yulin He, Cheng Peng et al. · Oncology Letters · 2018 · 51 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 20